The law normally requires people who offer financial products to give information to investors before they invest. This information is designed to help investors make an informed decision.
If you are a wholesale investor under the definition of that term in clause 3 of Part 1 Schedule 1 of the Financial Markets Conduct Act 2013, the usual rules do not apply to offers of financial products made to you. As a result, you may not receive a complete and balanced set of information.
You will also have fewer other legal protections for these investments. Ask questions, read all documents carefully, and seek independent financial advice before committing yourself.
The opportunity exists for wholesale investors to express interest in an investment in InsituGen.
The greatest threats to athletic integrity are designer performance enhancing drugs. These drugs are notoriously hard to identify. Every measure designed to identify a doping agent is circumvented by a new designer drug.
In response, InsituGen have developed a novel test to detect doping, not by looking for a specific drug, but by detecting chemical mechanisms common to entire classes of drugs - this makes engineering new undetectable drugs much more difficult. The company is currently focused on catching drug cheats in the horse & camel racing industries and expects to extend its product range to human athlete testing within twelve months.
Doping in racing not only compromises the fairness and authenticity of the sport it also has the potential for welfare concerns because many performance enhancing drugs, masking agents, or recovery drugs, are not clinically approved, especially at the doses used. As a result, to maintain the integrity of racing stables and the fairness for racing fans, testing racehorses for the presence of banned substances has become very well executed and regulated. InsituGen's products have the potential to rapidly improve anti-doping screening in the racing industry.
Pacific Channel is leading an investment into Insitugen investment and $2.2m is spoken for currently. Pacific Channel has also secured the right to place co-investment of $3 million on the same terms. The pre money valuation is $8.5 million. Funds will be used to secure market share in the animal racing industry, product development for human athlete testing and product validation in the Veterinary Diagnostic market.
InsituGen is an attractive investment for three primary reasons:
Please click here for a recent presentation made to existing shareholders and prospective investors.
You are almost registered. Please complete the following details.